PATRYS LIMITED (PAB)

Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
PAB	0.024	-4%	0.024	0.025	0.025	0.025	0.024	507,000

PATRYS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	PAB
Securities	ASX Code, Security Description ------------------------------ PAB, Ordinary Fully Paid
Official Listing Date	13 July, 2007
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.patrys.com
Registered Office Address	Suite 614, Level 6 Equitable House, 343 Little Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone	(03) 9670 3273
Head Office Fax	(03) 9670 3247
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr John Read (Non Exec. Chairman) Dr Marie Roskrow (Managing Director, CEO) Ms Suzy Jones (Non Exec. Director) Dr Alan Robertson (Non Exec. Director) Mr Michael Stork (Non Exec. Director) Mr Roger McPherson (CFO)

Company Secretary	Mr Roger McPherson
Principal Activities	Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.

PATRYS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
08/05/2013		PAT-SM6 Kills Human Multiple Myeloma Cells	3	PDF
06/05/2013		Patrys Hosts 2nd IgM Conference	1	PDF
24/04/2013		Patrys Progresses MM Clinical Trial to 3rd Patient Group	2	PDF
22/04/2013		New Data Supports PAT-SM6 Profile as Anti-cancer Treatment	2	PDF
19/04/2013		Appendix 4C - Quarterly Cash Flow - March 2013	5	PDF
10/04/2013		Treatment of Second Patient Group in MM Trial Completed	2	PDF
20/03/2013		Preclinical Results Support PAT-SM6 MM Programme	2	PDF
07/03/2013		Data from 1st Cohort in Multiple Myeloma Trial	2	PDF
06/02/2013		Half Yearly Report and Accounts - December 2012	17	PDF
18/01/2013		Appendix 4C - Quarterly Cash Flow - December 2012	5	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
21 May 2013	0.025	4.17%	0.026	0.025	280,000
20 May 2013	0.024	-7.69%	0.026	0.024	431,615
17 May 2013	0.026	4%	0.026	0.025	1,020,000
16 May 2013	0.025	-3.85%	0.025	0.025	350,000
15 May 2013	0.026	-3.7%	0.027	0.026	940,300

* Volume of shares shown represents only those shares traded on ASX.

PATRYS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PAB. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PAB

Warrants & Structured Products

No warrants & Structured Products are available over the security PAB

ASX CFDs

No Contracts For Differences are available over the security PAB

MyASX: Login | Sign up